Featured Research

from universities, journals, and other organizations

Unraveling the 'black ribbon' around lung cancer

Date:
April 17, 2014
Source:
Michigan State University
Summary:
A study consisting of lung cancer patients, primarily smokers between the ages of 51 to 79 years old, is shedding more light on the stigma often felt by these patients, the emotional toll it can have and how health providers can help. Previous research has shown that lung cancer carries a stigma. Because lung cancer is primarily linked to smoking behaviors, the public's opinion of the disease can often be judgmental. Today, lung cancer remains the leading cause of cancer death globally.

It's not uncommon these days to find a colored ribbon representing a disease. A pink ribbon is well known to signify breast cancer. But what color ribbon does one think of with lung cancer?

Although white has been identified as the designated color, for many suffering from the disease, black may be the only one they think fits.

A Michigan State University study consisting of lung cancer patients, primarily smokers between the ages of 51 to 79 years old, is shedding more light on the stigma often felt by these patients, the emotional toll it can have and how health providers can help.

"It's eye opening when a patient says to you that they feel like lung cancer 'just gets shoved under the rug,'" said Rebecca Lehto, who led the project and is an assistant professor with MSU's College of Nursing. "Patients in one of the focus groups actually associated lung cancer with a black ribbon."

Previous research has shown that lung cancer carries a stigma. Because lung cancer is primarily linked to smoking behaviors, the public's opinion of the disease can often be judgmental. Today, lung cancer remains the leading cause of cancer death globally.

Yet Lehto indicates that up to 25 percent of lung cancer patients worldwide have never smoked. The World Health Organization has identified air pollution as a cause, and genetics also have been associated with the disease.

"No matter how a patient gets lung cancer, it shouldn't affect the care they receive or the role empathy should play," she said.

Lehto's goal is to raise awareness among health care providers about the additional burden stigma places on patients and develop patient care strategies that strengthen coping skills and symptom management.

"Understanding a disease from the patient's perspective is essential to providing the best medical care to anyone," she said.

The study evaluated feedback from four focus groups; a format Lehto suggests is uncommon in this particular area of research.

"There've been several studies examining lung cancer stigma, but most have relied on survey data" she said. "Most of the groups in this study had three to four people participating and relied on a group dynamic to foster discussion. The sessions actually appeared quite therapeutic…acting more like a peer group."

Lehto's key findings showed participants expressing guilt, self-blame, anger, regret and alienation relative to family and societal interactions. Yet, many also discussed feeling uncomfortable with their health care providers and even feared their care might be negatively affected because of their smoking background.

Although she admits more research is needed with larger, more diverse patient samples, she said her findings could help substantiate the patient perspective on a critical issue that is of sociological importance. Lehto hopes the results will encourage health care providers to examine their own perceptions about lung cancer stigma and be more aware of how it impacts the patient.

"Arming providers with rich, contextual information may help us put biases aside and heighten empathy and understanding," she said. "That would be a step in the right direction."


Story Source:

The above story is based on materials provided by Michigan State University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Rebecca H. Lehto. Patient views on smoking, lung cancer, and stigma: A focus group perspective. European Journal of Oncology Nursing, 2014; DOI: 10.1016/j.ejon.2014.02.003

Cite This Page:

Michigan State University. "Unraveling the 'black ribbon' around lung cancer." ScienceDaily. ScienceDaily, 17 April 2014. <www.sciencedaily.com/releases/2014/04/140417124517.htm>.
Michigan State University. (2014, April 17). Unraveling the 'black ribbon' around lung cancer. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/04/140417124517.htm
Michigan State University. "Unraveling the 'black ribbon' around lung cancer." ScienceDaily. www.sciencedaily.com/releases/2014/04/140417124517.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins